Results 211 to 220 of about 549,379 (280)

Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma

Annals of Oncology, 2018
Yok-lam Kwong, Si-Ho Kim, Eric Tse, S. Oh, J. Kwak, H. Eom, Y. Do, Y. Mun, Se Ryeon Lee, H. Shin, C. H. Suh, S. Chuang, Yunsup Lee, Soon Thye Lim, K. Izutsu, Ritsuro Suzuki, T. Relander, F. d'Amore, Norbert Schmitz, Arnaud Jaccard, W. Kim   +20 more
semanticscholar   +1 more source

Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy

EBioMedicine, 2019
C. Xie, Pengfei Yang, Xue-bang Zhang, Lei Xu, Xiaoju Wang, Xiadong Li, Luhan Zhang, Ruifei Xie, Ling Yang, Z. Jing, Hongfang Zhang, L. Ding, Y. Kuang, T. Niu, Shixiu Wu   +14 more
semanticscholar   +1 more source

Nanotechnology in brain cancer treatment: The role of gold nanoparticles as therapeutic enhancers

Ibrain, Volume 11, Issue 2, Page 119-145, Summer 2025.
This review highlights the potential of gold nanoparticles (AuNPs) in overcoming the blood‐brain barrier (BBB) to improve brain tumor treatment. By enabling targeted drug delivery and enhancing therapies like radiotherapy, phototherapy, and chemotherapy, AuNPs offer a promising approach for safer, more effective treatments of glioblastoma and other ...
Simona Tarantino, Annalisa Bianco, Valeria De Matteis, Edoardo Scarpa, Rosaria Rinaldi   +4 more
wiley   +1 more source

Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locally advanced nasopharyngeal carcinoma

Cochrane Database of Systematic Reviews, 2013
Zhang Yu Zou, Song Qu, Jun Xia, Zhi Rui Zhou   +3 more
openaire   +3 more sources

Abstracts

Molecular Oncology, Volume 19, Issue S1, Page 1-895, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Gut‐derived Lactobacillus from exceptional responders mitigates chemoradiotherapy‐induced intestinal injury through methionine‐driven epigenetic modulation

iMeta, Volume 4, Issue 3, June 2025.
Using metagenomic sequencing and bioinformatics analysis of fecal samples from rectal cancer patients and corresponding mouse models, our study identifies a strong association between Lactobacillus abundance and acute chemoradiotherapy‐induced intestinal injury (ACRIII). Elevated Lactobacillus levels before treatment were consistently linked to reduced
Lu Yu, Zhenhui Chen, Shengqi Yin, Qiqing Guo, Yuchuan Chen, Jiaying Li, Yafang Wang, Xiangqiang Liu, Zi Xu, Yaowei Zhang, Yuqin Zhang, Zhihao Zheng, Keli Chen, Yanqing Ding, Hongying Fan, Zhifeng Liu, Yi Ding   +16 more
wiley   +1 more source

Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer

Journal of Surgical Oncology, Volume 131, Issue 7, Page 1293-1301, June 2025.
ABSTRACT Background and Objectives Standard treatment of patients with stage II/III esophageal or gastroesophageal junction (E/GEJ) cancer involves neoadjuvant chemoradiation (nCRT), resection, and immunotherapy. Our trial evaluated the addition of perioperative avelumab to standard treatments.
Nataliya V. Uboha, Mustafa M. Basree, Jens C. Eickhoff, Dustin A. Deming, Kristina Matkowskyj, James Maloney, Daniel McCarthy, Malcolm DeCamp, Noelle LoConte, Philip B. Emmerich, Sean Kraus, Monica A. Patel, Jeremy D. Kratz, Sam J. Lubner, Newton Hurst, Michael F. Bassetti   +15 more
wiley   +1 more source

A CASE OF DELAYED LYMPH NODE RECURRENCE AFTER CURATIVE ESOPHAGECTOMY FOR BASALOID-SQUAMOUS CARCINOMA OF THE ESOPHAGUS, SUCCESSFULLY TREATED WITH CONCURRENT CHEMORADIOTHERAPY

, 2009
Masato Maeda, Jun Nakagawa, Toshiki Kobayashi, Takuo Takehana, Kei Yonezawa, Tadashi Miyashita   +5 more
openalex   +2 more sources

Association of SIRT6 Expression With Risk of Pneumonitis Induced by Radiotherapy in Cancer Patients

Molecular Carcinogenesis, Volume 64, Issue 6, Page 1104-1118, June 2025.
ABSTRACT Thoracic tumours represent a significant proportion of malignant cancers. While radiotherapy (RT) improves prognosis, it can also lead to side effects such as radiation‐induced pneumonitis (RP). Since SIRT6 is involved in DNA repair, energy metabolism and inflammation, this study aims to investigate the expression of SIRT6 in lymphocytes as a ...
Fengyuan Yu, Zheng Gong, Yuan Li, Danial F. Naseem, Chen Li, Miaowei Wen, Bingying Zhao, Zhezhe Xu, Shanshan Zhang, Rukun Zang, Ailu Wu, Qingxin Han, Shuhui Wu, Hongwei Li, Yipeng Song   +14 more
wiley   +1 more source

Prospective Trial Incorporating Pre-/Mid-Treatment [18F]-Misonidazole Positron Emission Tomography for Head-and-Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy

, 2009
Nancy Y. Lee, Sadek A. Nehmeh, Heiko Schöder, Matthew G. Fury, Kelvin Chan, C. Clifton Ling, John L. Humm   +6 more
openalex   +1 more source